Targeting tumour vasculature as a cancer treatment

DOI10.1080/17486700701298319zbMATH Open1120.92021OpenAlexW2161852385MaRDI QIDQ2373333FDOQ2373333

Christopher A. Honstvet, P. F. Jones

Publication date: 17 July 2007

Published in: Computational \& Mathematical Methods in Medicine (Search for Journal in Brave)

Full work available at URL: https://eudml.org/doc/224379

zbMATH Keywords

AngiogenesisAnti-angiogenesisVascular disrupting agentsVessel regression

Mathematics Subject Classification ID

Medical applications (general) (92C50)

Cited In (1)

• Anti-angiogenic therapy based on the binding to receptors

   Recommendations

• A therapy inactivating the tumor angiogenic factors 👍 👎
• Tumour-Induced Angiogenesis: A Review 👍 👎
• Optimal protocols for the anti-VEGF tumor treatment 👍 👎
• Quantitative model for efficient temporal targeting of tumor cells and neovasculature 👍 👎
• AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem 👍 👎
• Tumour angiogenesis model with variable vessels' effectiveness 👍 👎
• Modelling tumour-induced angiogenesis 👍 👎
• Angiogenesis and vascular remodelling in normal and cancerous tissues 👍 👎
• Tumour angiogenesis: the gap between theory and experiments 👍 👎

This page was built for publication: Targeting tumour vasculature as a cancer treatment

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2373333)